
Drug Discovery
Theranostics: How nuclear medicine is changing precision oncology
Nuclear medicine's theranostics approach enables "see it, treat it" cancer therapy using the same agents for diagnosis and treatment. Investment tripled to $14.86B in 2024 as these precision treatments move to early-stage care.
Read the reportRead the articleDownload the summarySee the infographicRead the publicationRead the recapWatch the video